Navigation Links
Chewable Tablet Might Offer New Help for Diabetes Patients
Date:1/8/2014

MANCHESTER, N.H., Jan. 8, 2014 /PRNewswire/ -- Among those with Type 2 diabetes, the body either resists the effects of insulin, or the pancreas doesn't produce enough insulin to maintain a normal glucose level. What if these patients implemented a healthier diet and regular exercise?

According to R. Paul Robertson, M.D., president, Medicine and Science, of the American Diabetes Association, diabetes can be made to go into remission, but it will always be there. But, he says, patients can make significant strides against the disease, often to the point of quitting medication. The good news is that for some people who have lost weight, kept blood sugar levels stable, eat right and work out, doctors may allow them to go off their medications. 

As researchers strive for improved treatment options, the best one can do right now is to eat right, exercise and watch for complications. Oh, and one more thing: watch for PAZ320. Currently being developed by Boston Therapeutics, Inc., a Manchester, NH-based pharmaceutical company, PAZ320 is a non-systemic, non-toxic chewable drug candidate that is designed to inhibit enzymes that release glucose from complex carbohydrates in foods during digestion. In a Phase IIa study last year, 45 percent of Type 2 diabetes patients taking metformin responded to PAZ320 with a 40 percent reduction of post-meal glucose in the blood. 

David Platt, Ph.D., Boston Therapeutics' CEO, explains that they set out to make one molecule that would block enzymes that participate in the digestion of sugar. The resulting polysaccharide—a new class of drugs called carbohydrate hydrolyzing enzyme inhibitors (CHEI)—is taken before meals, working in the gastrointestinal tract to "disable" the carbs. In other words, it blocks the action of carbohydrate-hydrolyzing enzymes that break carbohydr
'/>"/>

SOURCE Boston Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Launches Generic Version of Zyprexa® Tablets
2. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
3. Mylan Launches Generic Version of Plavix® Tablets
4. Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
5. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
6. Mylan Launches Generic Version of Viramune® Tablets
7. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
8. FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet
9. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
10. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
11. Qualitest Receives FDA Approval for Levetiracetam Extended-Release Tablets, 500mg and 750mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Decision Resources ... in the EU5 countries ( France , ... , Spain and the ... view of the first once-daily long-acting beta2 agonist/inhaled corticosteroid ... robust uptake of Relvar as a first-line LABA/ICS FDC ...
(Date:7/24/2014)... BOSTON , July 24, 2014 Boston ... on Tomorrow (#PedInno14), will feature an "Innovation Tank" ... innovators an opportunity to pitch their business or product ... of funding and feedback on how to accelerate the ... competition, occurring the morning of Friday, October 31, will ...
(Date:7/24/2014)... IRVING, Texas , July 24, 2014 /PRNewswire/ ... in the cardiovascular market that could impact patient ... Spring 2014 CV Watch , "Innovations in ... report provides hospitals with guidance and details on ... serve patient needs and understand how these options ...
Breaking Medicine Technology:Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 2New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 3
... 16 The following is being,issued by Trust ... call to discuss a new report from the,American ... Health (TFAH),"Pandemic Influenza: Warning, Children At-Risk." The report ... for children during a possible,pandemic flu outbreak and ...
... Oct. 16 Boston Scientific,Corporation (NYSE: ... the Company,s major,events and press announcements at ... Cardiovascular Therapeutics (TCT),scientific symposium, which runs from ... Boston Scientific will be announcing a ...
Cached Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 3Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 4Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 5Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 6Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 7
(Date:7/24/2014)... semen is naturally colonized by bacteria, and a new study ... both HIV transmission and levels in infected men. U.S. ... play a role in local inflammation and in the production ... to possible targets for reducing transmission of the AIDS-causing virus. ... changes in HIV levels, and the researchers say more research ...
(Date:7/24/2014)... the body,s own immune system play a role in ... chronic epilepsy, Alzheimer,s dementia and concussions? Cleveland Clinic researchers ... PLOS ONE . , The study focuses on ... serves as a biomarker for brain damage. Normally, S100B ... However, following a brain injury, it can leak through ...
(Date:7/24/2014)... to transform into an aggressive form of cancer, are ... the metastasis or, even better, prevent their formation would ... Researchers at Universit catholique de Louvain (Belgium) successfully performed ... mice. The results of their study are published ... Cell Reports . , The work by Professor Pierre ...
(Date:7/24/2014)... prenatal ultrasounds uncover antenatal hydronephrosis, or enlarged kidneys, ... United States. Many children with this abnormality are ... few years of life with the hopes of ... recently, however, little evidence existed as to the ... and inconvenience for families. But a study published ...
(Date:7/24/2014)... The Biofeedback Federation of Europe is ... game development company Zukor Interactive. The agreement provides ... Zukor's Grind , a next-generation feedback game ... and international markets. , Zukor's Grind is a ... as a biofeedback/neurofeedback training tool. Typical training provides ...
Breaking Medicine News(10 mins):Health News:Bacteria in Semen May Affect HIV Transmission, Levels: Study 2Health News:Immune response may cause harm in brain injuries, disorders 2Health News:A world first: Researchers identify a treatment that prevents tumor metastasis 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 3Health News:Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive 2Health News:Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive 3
... chromosome lineage reveals farming influence , TUESDAY, Jan. 19 (HealthDay ... farmers who migrated from the Near East 10,000 years ago, ... Y chromosome, which is passed from father to son. , ... by about 110 million men -- it follows a gradient ...
... A.M. , Justin Herman Plaza , Market ... www.walkforlifewc.c o m , Speakers and organizers are available ... A woman who walked away from her job as a clinic director at ... on exposing abuses in the abortion industry will speak at the 6th Annual Walk ...
... , MIDLAND, ... adopt lifelong healthy behaviors with Health Enhancement Systems, ( ... The online program, 5 on 5 ( www.5on5.com ... habits wrapped in an exciting basketball tournament format. Participants form teams of ...
... , STRATHAM, N.H. ... world,s leading producer of premium chocolate, announces it is accepting nominations for ... the second year, Lindt will honor ordinary individuals who are extraordinary champions ... Lindt Unsung Heroes of Autism program is part of Lindt,s partnership with ...
... ,greater than, problems, study suggests , TUESDAY, Jan. 19 ... math? , A German team of neurobiologists has found ... using specific brain cells dedicated to the comprehension of ... insight into the neurology behind human ability to comprehend ...
... , TAMPA, Fla. , Jan. 19 ... Preventative Task Force (USPTF), the Obesity Action Coalition (OAC) is ... coverage of the recommended childhood obesity treatments. , The recommendations ... in moderate to intensive programs helps children affected by obesity ...
Cached Medicine News:Health News:6th Annual Walk for Life West Coast Saturday, January 23, 2010 2Health News:Corporate Teams Score Points for Healthy Eating 2Health News:Corporate Teams Score Points for Healthy Eating 3Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 2Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 3Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 4Health News:Monkey Brain 'Hardwired' for Simple Math 2Health News:Monkey Brain 'Hardwired' for Simple Math 3Health News:Obesity Action Coalition Calls on Insurers and Employers to Increase Access to Childhood Obesity Treatments Based on Recent United States Preventative Task Force Recommendations 2
Gently curved shaft with blunt angled tip is ideal for chopping the lens during anterior chamber phacoemulsification....
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique to be used in left hand. Round knurled handle....
Flat 7 mm wide hook. Flat serrated handle with polished finish. Overall length: 5.1 inches....
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
Medicine Products: